Subscribe Register Login

Tuesday, October 25, 2016, 4:13 p.m.
Top Picks - Mobile App

High court won't reconsider Risperdal case

By The Associated Press

This article was published April 24, 2014 at 10:33 a.m.

LITTLE ROCK — The Arkansas Supreme Court says it will not reconsider its decision to reject a $1.2 billion judgment against a pharmaceutical company accused of improperly marketing an antipsychotic drug.

Justices last month overturned a Pulaski County ruling that favored the state. In a 4-3 decision Thursday, the court turned down a request by Attorney General Dustin McDaniel to consider the case again.

McDaniel had said the court was wrong when it said the state misapplied a Medicaid fraud law in its case against New Jersey-based Johnson & Johnson and a subsidiary over the drug Risperdal.

The state had claimed Janssen Pharmaceuticals Inc. didn't properly communicate the drug's risks and shouldn't have marketed it for off-label use. The company said there was no fraud and that Arkansas' Medicaid program wasn't harmed.


Comments on: High court won't reconsider Risperdal case

To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Read our Terms of Use policy.

Subscribe Register Login

You must login to make comments.



Top Picks - Mobile App
Arkansas Online